Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-DDC Antibody (R1R63)

Catalog #:   RHD41201 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: P20711
Overview

Catalog No.

RHD41201

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

DOPA decarboxylase, DDC, AADC, Aromatic-L-amino-acid decarboxylase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P20711

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1R63

Data Image
  • Western blot
    Western blot analysis of DOPA Decarboxylase expression in (1) 293T cell lysate; (2) RAW 264 .7 cell lysate.
References

Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment., PMID:40171657

Multi-epitope vaccines Xlc and Ddc against Glaesserella parasuis infection in mice., PMID:40154005

Linking single-cell transcriptomes with secretion using SEC-seq., PMID:39979460

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study., PMID:39676868

Modulation of Notch signaling pathway in activated hepatic stellate cells does not ameliorate the outcome of liver fibrosis in carbon tetrachloride and DDC-feeding models., PMID:39529885

[Clinical, endoscopic, laboratory and immunomorphological parameters in predicting the occurrence of colorectal cancer in patients with diverticular disease of the colon]., PMID:39404716

Rapid single-tier serodiagnosis of Lyme disease., PMID:39164226

Comparative outcomes of DSA positive, crossmatch negative living donor kidney transplants versus remaining on the waitlist for an HLA compatible deceased donor., PMID:39074764

Metabolic Response to Small Molecule Therapy in Colorectal Cancer Tracked with Raman Spectroscopy and Metabolomics., PMID:38995663

Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation., PMID:38832336

Real-world pharmacological treatment of pregnant patients with rheumatic diseases from China: a retrospective analysis from 2016 to 2021., PMID:38694907

Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials., PMID:38588819

Defining T cell receptor repertoires using nanovial-based binding and functional screening., PMID:38536748

Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials., PMID:38447700

Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection., PMID:38400163

Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta Variant., PMID:38334597

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates., PMID:38236580

Proceedings of the inaugural Dark Genome Symposium: November 2022., PMID:37990347

Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila., PMID:37442493

Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial., PMID:37371853

Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease., PMID:37348790

SEC-seq: association of molecular signatures with antibody secretion in thousands of single human plasma cells., PMID:37322036

The HAVEN study-hydroxychloroquine in ANCA vasculitis evaluation-a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan., PMID:37024906

Lipopolysaccharide-binding protein expression is increased by stress and inhibits monoamine synthesis to promote depressive symptoms., PMID:36854305

Tim-3 downregulation by Toxoplasma gondii infection contributes to decidual dendritic cell dysfunction., PMID:36303229

Trends in anti-HER2 drugs consumption and influencing factors., PMID:36159303

Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome., PMID:35907342

Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies., PMID:35844072

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration., PMID:35705376

Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22., PMID:35464476

Functional characterization of CD49f+ hepatic stem/progenitor cells in adult mice liver., PMID:35166962

Label-free LC-HRMS-based enzymatic activity assay for the detection of DDC, MAO and COMT inhibitors., PMID:35152005

Bimekizumab versus Secukinumab in Plaque Psoriasis., PMID:33891380

Bimekizumab versus Adalimumab in Plaque Psoriasis., PMID:33891379

Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme., PMID:33568389

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small-Cell Lung Cancer., PMID:33340277

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors., PMID:32753546

Investigation of Measles Outbreak among Thai and Migrant Workers in Two Factories in Nakhon Pathom, Thailand, 2019., PMID:32605070

Single-Domain Antibodies as Crystallization Chaperones to Enable Structure-Based Inhibitor Development for RBR E3 Ubiquitin Ligases., PMID:31813847

Computational cytometer based on magnetically modulated coherent imaging and deep learning., PMID:31645935

Pipe-3D: A Pipeline Based on Immunofluorescence, 3D Confocal Imaging, Reconstructions, and Morphometry for Biliary Network Analysis in Cholestasis., PMID:31016646

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients., PMID:30811063

L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin., PMID:30796964

Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study., PMID:29128267

Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics., PMID:29035675

Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation., PMID:28289923

Involvement of prolyl isomerase PIN1 in the cell cycle progression and proliferation of hepatic oval cells., PMID:28214206

Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal., PMID:28073888

Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related to IL-12 signaling., PMID:27965154

Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells., PMID:27739521

Datasheet

Document Download

Anti-DDC Antibody (R1R63).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-DDC Antibody (R1R63) [RHD41201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only